@FierceMedDev: Check out this year's Fierce 15: The new strategic med tech mania sets the stage for 2015's Fierce 15. Feature | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Silk Road reels in $57M to commercialize its system for stroke prevention. Article | Follow @VarunSaxena2
@EmilyWFierce: Subway ups the ante on antibiotic-free meat pledge. FierceAnimalHealth story | Follow @EmilyWFierce
> C2 Therapeutics has gained a CE mark for its Coldplay CryoBalloon Focal Ablation System to treat the precursor to esophageal cancer. More
> Insightec has submitted a PMA with the FDA for approval of its MR-guided, focused ultrasound device Exablate Neuro to treat essential tumor. More
> Reuters ran an article on how the unhealthy but routine habits at hospitals, like interrupted sleep and poor nutrition, could be making patients sicker. Story
Biotech News
@FierceBiotech: Gene therapy for brain protein boosts memory in aged mice. FierceBiotechResearch article | Follow @FierceBiotech
@JohnCFierce: Moderna launches the 3rd or 4th personalized cancer vaccine co. in a month. Release | Follow @JohnCFierce
@DamianFierce: Casting the Coen Bros. $VRX movie: Clooney obviously plays Ackman, and then maybe John Goodman for Pearson. William H. Macy as Pyott? | Follow @DamianFierce
> AIT pushes ahead with plans for $40M Nasdaq IPO. Report
> Relypsa wins patiromer OK but gets hammered on black box restrictions. Story
> Moderna joins the personalized cancer vaccine rush with third new venture. Article
> FierceBiotech Radio on doomsdays for Valeant, Biogen and biotech VC. More
Pharma News
@FiercePharma: Parnell shares advance on strong Q3 revenue growth. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI: After shutting plant over mold issues, France's TxCell decides using CMOs makes more sense. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: Good news for Allergan: Men want to treat wrinkles. Bad? They're clueless about products. FiercePharmaMarketing article | Follow @CarlyHFierce
> Perrigo to slash 800 jobs, buy back $2B of its stock in move to fend off Mylan. Story
> Compounder targets Turing's now-pricey Daraprim with $1-per-pill alternative. Article
> Valeant shares nosedive on short seller's 'phantom sales' allegations. Report
CRO News
> Quintiles pairs up with IMS to use real-world data in Phase III trials. Report
> BioClinica revamps its CRO partner program. Item
> SRI inks a $100M contract with NIH to study treatments for radiation exposure. More
> Quintiles shuffles its C-suite with new CFO, COO. News
> Evotec partners up for rare disease R&D in a discovery deal. Article
Pharma Manufacturing News
> Roche partner Chugai significantly expanding antibody capacity at Japan plant. Story
> Biogen's manufacturing feels the pain of its cost-cutting. Report
> Perrigo to consolidate supply chain operations as part of downsizing. Item
> Feds get guilty pleas from suppliers in massive drug diversion operation. More
> AstraZeneca opens plant in Russia. News
Pharma Asia News
> Abbott still eager for emerging markets, but currency headwinds an issue. Article
> Asia's dengue epidemic highlights race for treatment, vaccine options. More
> Chinese hackers said to target U.S. tech and pharma companies. Report
> BeiGene heads to Nasdaq with $100M IPO in China oncology boom. Story
> Yabao expands ties in diabetes pact with a busy Eli Lilly in China. Article